A

Alterity Therapeutics Limited
D

ATHE

1.05000
USD
-0.08
(-7.08%)
Market Closed
Volume
2,132
EPS
-1
Div Yield
-
P/E
-1
Market Cap
9,179,901
OverviewSignalsIdeasNews
Related Instruments
    A
    ATEC
    -0.50000
    (-5.72%)
    8.23500 USD
    A
    ATHA
    -0.03290
    (-4.63%)
    0.67800 USD
    A
    ATHX
    0.00290
    (2.96%)
    0.10100 USD
    A
    ATOS
    -0.09000
    (-6.57%)
    1.28000 USD
    More
News

Title: Alterity Therapeutics Limited

Sector: Healthcare
Industry: Biotechnology
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.